StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.0
  1. Startseite
  2. /Reaktion

NADP nicotinamide-adenine-dinucleotide phosphate → (S)-N-[5-(1,2-dihydroxy-ethyl)-pyrazin-yl]-2,2-dimethyl-propionamide

HRID 12001
Notizen
Druckvorschau

Reaktionsgleichung

Reaktionsgleichung von HRID 12001
[CH3:1][C:2]([CH3:20])([CH3:19])[C:3]([NH:5][C:6]1[N:7]=[CH:8][C:9]([C:12](=[O:18])[CH2:13][O:14]C(=O)C)=[N:10][CH:11]=1)=[O:4].O=C[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O.C1C=[N+]([C@@H]2O[C@H](COP(OP(OC[C@H]3O[C@@H](N4C5N=CN=C(N)C=5N=C4)[C@H](OP(O)(O)=O)[C@@H]3O)(O)=O)(O)=O)[C@@H](O)[C@H]2O)C=C(C(N)=O)C=1.[OH-].[Na+]>COC(C)(C)C.O=C[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O>[OH:18][C@@H:12]([C:9]1[N:10]=[CH:11][C:6]([NH:5][C:3](=[O:4])[C:2]([CH3:19])([CH3:1])[CH3:20])=[N:7][CH:8]=1)[CH2:13][OH:14]
KomponentenReaktionsbedingungenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion

Komponenten

7

Edukt 4

HCID 5886NADP nicotinamide-adenine-dinucleotide phosphateHCID 14798Sodium HydroxideHCID 107526(2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanalHCID 44248502Acetic acid 2-[5-(2,2-dimethylpropionylamino)-pyrazin-2-yl]-2-oxo-ethyl ester

Produkt 1

HCID 51349106(S)-N-[5-(1,2-dihydroxy-ethyl)-pyrazin-yl]-2,2-dimethyl-propionamide
Ausbeute 105,1 %

Reagenzien, Katalysatoren, Lösungsmittel 2

HCID 107526(2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanalKatalysatorHCID 15413tert-Butyl methyl etherLösungsmittel

Reaktionsbedingungen

Temperatur
37 °C

Versuchsvorschrift

50 g of acetic acid 2-[5-(2,2-dimethylpropionylamino)-pyrazin-2-yl]-2-oxo-ethyl ester (178 mmol) was stirred in 150 ml tert-butyl methyl ether (TBME). Subsequently the reaction buffer, 674 mL 20 mM of 2-(4-morpholino)-ethansulfonic acid, and 100.1 g of D-glucose (658 mmol) were added. The temperature was adjusted to 29° C. and the pH to 6.25. The reaction—deacetylation—was started by the addition of 2.01 g lipase AH. Directly afterwards, 40 mg of glucose dehydrogenase GDH 102, 201 mg of ketoreductase KRED 101 and 202 mg of cofactor NADP were added to initiate the asymmetric reduction. The reaction temperature was increased up to 37° C. The stirred suspension was maintained at pH 6.25 (and 37° C.) by the controlled addition (pH-stat) of 1.0 N sodium hydroxide solution. After 11.2 h, after a total consumption of 354.1 mL of 1.0 N sodium hydroxide, and after complete conversion, the reaction mixture was stirred for further 10.5 h. For the product extraction 300 g of sodium chloride were added into the reaction mixture and the pH was adjusted to 7.5. Subsequently, the reaction mixture was extracted 5 times with 1 L of ethyl acetate. The phase separation occurred spontaneously. The combined organic phases were dried over anhydrous sodium sulfate, evaporated and dried on HV over night. 44.76 g (S)—N-[5-(1,2-dihydroxy-ethyl)-pyrazin-yl]-2,2-dimethyl-propionamide (4) (96.4% HPLC purity, [SupelcoSil ABZ+, 250×4.6 mm, eluent 20-90% acetonitrile/water+0.1% TFA over 10 min at 1 mL/min, detection at UV 300 nm, retention time 5.3 min], ee>99.9% [Chiralpak IA, 250×4.6 mm, 5 μm, eluent 50% Heptane 50% Ethanol/Methanol 1:1 over 20 min at 1 mL/min, detection at UV 240 nm, retention time enantiomers 9.3 and 10.9 min]) were isolated as a light orange, highly viscous oil.

Aufarbeitung

  1. customwas adjusted to 29° C.
  2. additionThe reaction—deacetylation—was started by the addition of 2.01 g lipase AH
  3. additionwere added
  4. customafter a total consumption of 354.1 mL of 1.0 N sodium hydroxide
  5. extractionFor the product extraction 300 g of sodium chloride
  6. additionwere added into the reaction mixture
  7. extractionSubsequently, the reaction mixture was extracted 5 times with 1 L of ethyl acetate
  8. customThe phase separation
  9. dry with materialThe combined organic phases were dried over anhydrous sodium sulfate
  10. customevaporated
  11. customdried on HV over night

Quellen und Nachweise

ORD-Eintrag
ord-a51e3f161c854b78a1d46c42a07deb48
Quelldatensatz
uspto-grants-2010_06
DOI
10.6084/m9.figshare.5104873.v1
Patentnummer
US07727750B2

Notizen zur Reaktion

Wird geladen…

Auf dieser SeiteKomponentenReaktionsbedingungenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion